Medgenics Inc (NYSE MKT LLC:MDGN)
| 4.15 Data as of 9:52am ET | Today’s Change | 3.66 Today|||52-Week Range 16.43 | -44.22% Year-to-Date |
Latest MDGN News | Press Releases
No recent news for Medgenics Inc.
Today’s Trading
| Previous close | 4.15 |
| Today’s open | 4.08 |
| Day’s range | 4.08 - 4.15 |
| Volume | 1,550 |
| Average volume (3 months) | 46,316 |
| Market cap | $76.7M |
| Dividend yield | -- |
Data as of 9:52am ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZLCSZalicus Inc | +0.02 | +3.28% |
| ALXAAlexza Pharmaceutica... | +0.01 | +0.21% |
| ORMPOramed Pharmaceutica... | -0.05 | -0.49% |
| --Ophthalix Inc | 0.00 | 0.00% |
Data as of 10:04am ET, 05/22/2013
Financials
| Next reporting date | August 19, 2013 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts

